ADHERENCE TO NUTRITIONAL SUPPLEMENTATION, FOLLOW-UP CARE, AND LOST TO FOLLOW-UP IN POST BARIATRIC SURGERY PATIENTS.

Background: With the global rise in obesity rates, bariatric surgery has emerged as an effective intervention for weight management and obesity-related comorbidities. Bariatric surgery offers transformative potential but demands lifelong adherence to multifaceted care, including nutritional supplementation and vigilant follow-up. Nutritional deficiencies affect 30% to 70% of patients, encompassing vital elements like vitamins (B12, D, folate), minerals (iron, zinc, calcium), and proteins, necessitating continuous monitoring to prevent complications.

The Role of Alpha-Synuclein and Tubulin-Associated Unit (Tau) Proteins in the Diagnosis, Prognosis, and Treatment of Parkinson's Disease: A Systematic Review.

Parkinson's disease (PD) is a degenerative neurological disorder resulting from the death of dopaminergic neurons, which, in turn, results in impaired motor and cognitive functions. Early diagnosis is important in achieving a good prognosis for PD. Currently, the only approved way to diagnose PD is through medical history, current symptoms, and neurological examination.

The Role of Oral Probiotics in Alleviating Inflammation, Symptom Relief, and Postoperative Recurrence and Their Side Effects in Adults With Crohn's Disease: A Systematic Review.

Crohn's disease (CD) is a lifelong problem for patients, despite having multiple pharmacological options and surgeries for treatment. In order to achieve best results, probiotics are being used even though their efficacy is still debatable. This systematic review analyzes the safety and efficacy of several probiotics in CD.

The Role of Hydrogen Sulfide in the Localization and Expression of p53 and Cell Death in the Nervous Tissue in Traumatic Brain Injury and Axotomy.

Traumatic brain injury (TBI) is one of the leading causes of disability and death worldwide. It is characterized by various molecular-cellular events, with the main ones being apoptosis and damage to axons. To date, there are no clinically effective neuroprotective drugs.